Oruka Therapeutics (ORKA) Prepaid Assets (2010 - 2026)
Oruka Therapeutics' quarterly Prepaid Assets came in at $6.4 million in Q1 2026, up 114.79% year-on-year from $3.0 million in Q1 2025, and down 5.77% quarter-over-quarter from $6.8 million in Q4 2025.
Oruka Therapeutics has reported Prepaid Assets for 17 years, with the latest figure at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 114.79% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 114.79% YoY), and the FY2025 full-year result was $6.8 million, up 457.99% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.4 million, down from $6.8 million in the prior quarter.
- The five-year high for Prepaid Assets was $6.8 million in Q4 2025, with the low at $161000.0 in Q4 2023.
- Average Prepaid Assets over 5 years is $2.1 million, with a median of $1.2 million recorded in 2022.
- Year-over-year, Prepaid Assets tumbled 76.08% in 2022 and jumped 658.39% in 2024.
- Tracing ORKA's Prepaid Assets over 5 years: stood at $254000.0 in 2022, then plunged by 36.61% to $161000.0 in 2023, then jumped by 658.39% to $1.2 million in 2024, then jumped by 457.99% to $6.8 million in 2025, then declined by 5.77% to $6.4 million in 2026.
- The last three Prepaid Assets figures came in at $6.4 million (Q1 2026), $6.8 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 6.81 Mn |
| Sep 30, 2025 | 6.01 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 537,000.00 |
| Mar 31, 2024 | 767,000.00 |
| Dec 31, 2023 | 161,000.00 |
| Sep 30, 2023 | 405,000.00 |
| Jun 30, 2023 | 599,000.00 |
| Mar 31, 2023 | 852,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | 611,000.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 1.60 Mn |
| Mar 31, 2021 | 1.80 Mn |
| Dec 31, 2020 | 897,000.00 |
| Sep 30, 2020 | 841,000.00 |
| Jun 30, 2020 | 532,000.00 |
| Mar 31, 2020 | 704,000.00 |
| Dec 31, 2019 | 117,000.00 |
| Sep 30, 2019 | 259,000.00 |
| Jun 30, 2019 | 357,000.00 |
| Mar 31, 2019 | 513,000.00 |
| Dec 31, 2018 | 169,000.00 |
| Sep 30, 2018 | 336,000.00 |
| Jun 30, 2018 | 375,000.00 |
| Mar 31, 2018 | 631,000.00 |
| Dec 31, 2017 | 547,000.00 |
| Sep 30, 2017 | 425,000.00 |
| Jun 30, 2017 | 648,000.00 |
| Mar 31, 2017 | 643,000.00 |
| Dec 31, 2016 | 282,000.00 |
| Sep 30, 2016 | 320,000.00 |
| Jun 30, 2016 | 377,000.00 |
| Mar 31, 2016 | 391,000.00 |
| Dec 31, 2015 | 114,000.00 |
| Sep 30, 2015 | 205,000.00 |
| Jun 30, 2015 | 241,000.00 |
| Mar 31, 2015 | 490,000.00 |
| Dec 31, 2014 | 134,000.00 |
| Sep 30, 2014 | 216,000.00 |
| Jun 30, 2014 | 303,000.00 |
| Mar 31, 2014 | 599,000.00 |
| Dec 31, 2013 | 169,000.00 |
| Sep 30, 2013 | 379,000.00 |
| Jun 30, 2013 | 284,000.00 |
| Mar 31, 2013 | 456,000.00 |
| Dec 31, 2012 | 125,000.00 |
| Sep 30, 2012 | 184,000.00 |
| Jun 30, 2012 | 408,000.00 |
| Mar 31, 2012 | 475,000.00 |
| Dec 31, 2011 | 269,000.00 |
| Sep 30, 2011 | 340,000.00 |
| Jun 30, 2011 | 364,000.00 |
| Dec 31, 2010 | 137,000.00 |